Behind the Mystery: Understanding Pheochromocytoma and Paraganglioma
February 28, 2019
Learn About Pheochromocytoma and Paraganglioma, Known As Rare Neuroendocrine Tumors
Understanding Pheochromocytoma and Paraganglioma; rare neuroendocrine tumors that can dramatically impact survival in people of all ages. Every year in the US, fewer than 8 out of one million people are diagnosed with pheo or para tumors. But as many as 130,000 people are living with the disease in the US, although that number may be higher due to underdiagnosis. If pheo and para tumors are not diagnosed and appropriately treated, the disease will likely be fatal Dr. Joseph Dillon, Co-Director of the Neuroendocrine Tumor Clinic at the University of Iowa educates us on these rare tumors, symptoms to be aware of, and how patients should proceed if they are diagnosed.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.